Rapid identification of metallo- and serine beta-lactamases
Open Access
- 1 May 1994
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 38 (5) , 991-996
- https://doi.org/10.1128/aac.38.5.991
Abstract
Simple methods to detect, identify, and differentiate metallo- and serine beta-lactamases were developed and used to differentiate enzymes produced by 17 clinical isolates of Xanthomonas maltophilia. All isolates exhibited beta-lactamase activity, and in 16 strains this was induced by imipenem. All but one isolate hydrolyzed imipenem (and meropenem), and in all cases this activity was inhibited by 1 mM EDTA. The metallo- and serine beta-lactamases in the cell extracts were distinguished on isoelectric focusing (IEF) gels by using the following procedures. (i) Cell lysates were preincubated with 83 mM EDTA prior to IEF and subsequent visualization with nitrocefin, and (ii) after IEF, the gels were overlaid with either 1 mM zinc sulfate or 100 microM BRL 42715 before staining with nitrocefin. Bands of beta-lactamase activity which were removed by BRL 42715 but unaffected by EDTA or zinc sulfate were categorized as serine beta-lactamases. Bands which were unaffected by BRL 42715 but inhibited by EDTA or enhanced by zinc sulfate were classified as metallo-beta-lactamases. By using this approach, seven metallo-beta-lactamases were differentiated with pI values of 4.8 (two strains), 5.5 (four strains), 5.7 (one strain), 6.0 (one strain), 6.4 (four strains), 6.6 (one strain), and 6.8 (three strains). The metallo-beta-lactamase band with a pI of 6.4 aligned with the recently characterized metallo-beta-lactamase from X. maltophilia 511. Heterogeneity was also observed for the serine beta-lactamases: 14 isolates elaborated serine beta-lactamase activity which focused with major bands with at least eight different pIs. The remaining three strains produced serine beta-lactamases which focused with five distinct bands with pIs of 6.4, 6.2, 5.7, 5.5, and 5.2. We conclude that X. maltophilia produces many types of metallo- and serine beta-lactamases distinguishable by these new methods and that the previously reported L-1 and L-2 enzymes are not solely representative of the beta-lactamases produced by this species.Keywords
This publication has 14 references indexed in Scilit:
- Metallo-β-lactamases— new therapeutic challengeJournal of Medical Microbiology, 1993
- The Crisis in Antibiotic ResistanceScience, 1992
- Characterization of the plasmid mediated β-lactamase BIL-1Journal of Antimicrobial Chemotherapy, 1992
- The automated in-vitro assesment of β-lactamase inhibitorsJournal of Antimicrobial Chemotherapy, 1991
- Susceptibility to -lactam antibiotics of mutant strains of Xanthomonas maltophilia with high- and low-level constitutive expression of L1 and L2 -lactamasesJournal of Medical Microbiology, 1991
- Nosocomial Infection Caused by Xanthomonas maltophilia A Case-Control Study of Predisposing FactorsInfection Control & Hospital Epidemiology, 1990
- Heterogeneity of Beta-Lactamase Production in Pseudomonas maltophilia, a Nosocomial PathogenChemotherapy, 1990
- In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitorAntimicrobial Agents and Chemotherapy, 1989
- Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophiliaAntimicrobial Agents and Chemotherapy, 1982
- The Use of Analytical Isoelectric Focusing for Detection and Identification of -LactamasesJournal of General Microbiology, 1975